drugset / Trial / NCT03595228

BN Brachyury and Radiation in Chordoma

NCT03595228

Phase 2 Completed 29 enrolled Bavarian Nordic
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to determine if the combination of BN-Brachyury plus radiation therapy can induce objective radiographic response rate (ORR) in patients, using a Simon 2-stage optimal design. In stage 1, a minimum of threshold of activity is needed to proceed to stage 2.

Timeline

Start
2018-10-31
Primary completion
2021-12-10
Completion
2022-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject FPV-Brachyury Vaccine Other
Subject MVA-BN-Brachyury Vaccine Other

Indications